Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
Naloxone Access & Experience Survey
Help out researchers at Emory University School of Medicine by answering a short 5-15 minute survey on your thoughts about and experiences with naloxone and opiates. [ Go To Survey ]
Erowid Announcement #26
December 14, 2001
Greetings Entheophiles,

After a few weeks of instability and failed diagnostics with our server in October, the primary hardware was replaced. Happily, we're now back to running smoothly. Huge thanks to everyone who was involved with that upgrade.

As you've probably noticed, it's easy for us to decide to forego announcements during busy periods, so this announcement is the first since the end of September. We've been very busy (as usual) during the last couple months, with the most recent project being issue 2 of Erowid Extracts, our members newsletter. [What idiots decided to make a paper newsletter!? We're all fired!]

Members should receive issue 2 within a few days, assuming no problems with the postal service. Those of you who aren't Erowid members can now check out the first (May 2001) issue of Extracts online:

During the next couple of months we're hoping to focus on completing some new infrastructure at Erowid. The new design, including new headers, navigation, and document revision tracking, will better support the excellent volunteers we've been working with (thanks!) as well as helping us keep up with the growth of the site. We're excited about the upcoming changes.

Things continue to go well here. Hope you enjoy the new content. For a full list of new additions, see our What's New Page:

We welcome submissions, suggestions, criticisms, or corrections at

Fire, Sophie, & Earth


  1. New HPPD (Hallucinogen Persisting Perceptual Disorder) Vault

    Includes a new comprehensive HPPD FAQ, as well as several articles and a collection of links.

  2. MDMA Neurotoxicity Vault

    The collection of info on MDMA Neurotoxicity has grown large enough to warrant its own index. Includes a new overview of MDMA Neurotoxicity by Matthew Baggott from "Ecstasy: The Complete Guide".

  3. Major Update of Psychoactives & Sex Vault

    We've been meaning to expand this section for a while. New additions include some experience reports, links and a bibliography.

  4. Art Vaults Additions:

    Several new artists have been added to the emerging artists section. Cody Seekins is Erowid's Visionary Artist of the Month for December:

  5. Bupropion Basics

    A page of basic information about Buproprion (Wellbutrin/Zyban).

  6. Estimate of Prevalence of Use of Psilocybin Mushrooms

    A brief collection of some of the statistics available about how many people have used psilocybin mushrooms.

  7. Pharmacology of Psychoactive Amanitas

    A short overview of the active chemicals in Amanita muscaria.

  8. Barbiturates Images & Chemistry

    Two new pages about Barbiturates. Includes molecular images for three of the better known barbiturates.

  9. New MPTP Vault

    We've finally gathered together the stray pieces of information about MPTP that have been lying about...and made them into the beginning of a vault.

  10. New Adrenochrome Vault

    We get a lot of questions about adrenochrome (as a result of its mention in Fear and Loathing in Las Vegas), so we've put together some basic info.

  11. New GHV & GVL Vault

    Gamma Valerolactone is closely related to GHB. This is a new vault with basic chemistry, some journal references, and a couple of experiences.

  12. New Modafinil (Provigil) and Adrafinil Vaults

    Two closely related stimulants sold as smart drugs in some countries. Includes law, chemistry, health, journal references and some images.

  13. New Analog Act Vault

    Created a new vault for collecting information about both federal and state analog acts. Added info about related case law.

  14. Institute of Medicine Report on Caffeine & Mental Performance

    An interesting pieces from the IOM suggests they believe caffeine can be safely used to improve alertness and cognition. They even recommend dosages.

  15. Kava Law Update - Switzerland Bans Some Kava Products

    A few reported serious health problems related to kava prompted the Swiss government to ban certain kava products.

  16. Betel Nut Chewing & Cancer

    A brief intro to the issue of whether daily Betel Nut chewing may be associated with an increased risk of some cancers.

  17. Character Vault Additions

    New Elizabeth Gips page and revisions of John Lilly and Ken Kesey.

  18. Mushroom Cultivation: Fire Warning on Fast Food of the Gods Method

    Keep an eye on that tupperware!

  19. FDA Approves Research Into Medical Use of MDMA (Ecstasy)

    Media article about the FDA's approval of MDMA research project.

  20. Psilocybin May Reduce Some Obsessive Compulsive Disorders

    An interesting case report from 1996 regarding a disabling body image problem which were diminished in one individual in periods after taking psilocybin mushrooms.

  21. 50+ Image Vault Additions
    More than 50 new images were added. A few highlights:

    Methamphetamine crystals
    Passiflora cerulea
    20 New MDMA Tablets
    Datura inoxia seedpod
    Close-up of ground P. cubensis
    Small pile of 2C-B vials
    Bullet used for snorting powders

  22. 300 Experience Reports

  23. 24 Ask Erowid Questions

  24. Books Added to the Library / Bookstore
    We've added a number of new books and videos to the library. A few highlights are listed here:

    Psychopharmacology of Herbal Medicine (2001)
    Ecstasy: The Complete Guide (2001)
    Sacha Runa: Spirits of the Rain Forest (Video, 1996)

For a more complete listing of What's New at Erowid go to:

New results for tested tablets received and displayed between September 27 and December 14th 2001. Visit the submissions page to find out how to send in a tablet for free testing.


If you find Erowid a useful resource and are interested in supporting its future development, please consider donating or becoming a member.



To UNSUBSCRIBE - send an empty email to
To SUBSCRIBE - send an empty email to

or send your request to